Literature DB >> 20859777

Deviation versus violation plots: A new technique for assessing the self-consistency of NMR data.

M Adler1.   

Abstract

A new method has been developed to test the self-consistency of distance constraints derived from NOESY spectra. The technique is based on the premise that the further the atomic coordinates of any given structure vary from the 'correct' structure, the more NOE violations will occur in that structure. This relationship is quantified by plotting the deviation of each structure against the sum of the residual NOE violations. This type of plot is called a DVplot, which is generated by the following means: first the experimental constraints are used to generate a set of structures, then the amount of deviation and violation is quantified for each structure. The deviation of each structure is derived from the root-mean-squared deviation (rmsd) between each structure and the average structure. Violations are quantified for each structure using the new terms S1, S2, and S3. These terms measure the sum of all residual NOE violations greater than 0.1 A, 0.2 A, and 0.3 A, respectively. DVplots are used to show that for series of structures calculated from a single set of NMR constraints, there is an approximate linear correlation between the rmsd and each of the three sums, S1, S2, and S3. Furthermore, it is proposed that the x-intercepts derived from the three plots of S1, S2, and S3 will converge if the NOE constraints are selfconsistent. The new technique is applied to five different proteins using both experimental and simulated constraint sets.

Year:  1996        PMID: 20859777     DOI: 10.1007/BF00228143

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  9 in total

1.  A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G.

Authors:  A M Gronenborn; D R Filpula; N Z Essig; A Achari; M Whitlow; P T Wingfield; G M Clore
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

2.  Time-averaged nuclear Overhauser effect distance restraints applied to tendamistat.

Authors:  A E Torda; R M Scheek; W F van Gunsteren
Journal:  J Mol Biol       Date:  1990-07-05       Impact factor: 5.469

3.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

Authors:  A T Brünger
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

4.  High-resolution solution structure of the EGF-like domain of heregulin-alpha.

Authors:  N E Jacobsen; N Abadi; M X Sliwkowski; D Reilly; N J Skelton; W J Fairbrother
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

5.  The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin.

Authors:  M Adler; M H Seto; D E Nitecki; J H Lin; D R Light; J Morser
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

Review 6.  Assessment of quality of derived macromolecular structures.

Authors:  T L James
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Assessing the quality of solution nuclear magnetic resonance structures by complete cross-validation.

Authors:  A T Brünger; G M Clore; A M Gronenborn; R Saffrich; M Nilges
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

8.  Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.

Authors:  M Adler; R A Lazarus; M S Dennis; G Wagner
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

9.  The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures.

Authors:  S G Hyberts; M S Goldberg; T F Havel; G Wagner
Journal:  Protein Sci       Date:  1992-06       Impact factor: 6.725

  9 in total
  1 in total

1.  Automated detection of problem restraints in NMR data sets using the FINGAR genetic algorithm method.

Authors:  D A Pearlman
Journal:  J Biomol NMR       Date:  1999-04       Impact factor: 2.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.